Monoclonal Antibody Approved to Help Prevent Severe COVID in Vulnerable After Exposure

Published on August 4, 2021

A preventive monoclonal antibody injection for people at high risk for developing severe COVID-19 after exposure to the coronavirus has been approved by the U.S. Food and Drug Administration. The first dose of Regeneron’s cocktail must be injected within 96 hours of exposure…

Read Full Article (External Site)